{"entity":{"type":"insider","cik":"0001453042","url":"/insider/0001453042","json_url":"/insider/0001453042.json","name":"Roberts Thomas G. Jr.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":175,"n_filings":20,"first":"2009-03-25","last":"2025-08-21","span_basis":"filed_date"},"name_variants":[{"name":"Roberts Thomas G. Jr.","source":"filing","n_filings":20,"first_seen":"2009-03-25","last_seen":"2025-08-21"}],"transactions":[{"id":4488409,"accession":"0000908834-25-000269","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908834-25-000269","line_url":"/filing/0000908834-25-000269#line-2","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"Lantheus Holdings, Inc.","issuer_ticker":"LNTH","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"PATEL RAJIV A; Roberts Thomas G. Jr.; Saito Edric C.; Seybold William; Short Daniel S.; Spokes Andrew J M; WEHRLY MARK C; Warren John R.","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3365000.0,"shares_display":"3,365,000","price_per_share":56.15,"price_display":"56.15","price_state":"stated","total_value":188944750.0,"total_display":"188,944,750.00","shares_owned_after":3477227.0,"shares_owned_after_display":"3,477,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-21","scope":"insider"},{"id":4488403,"accession":"0000908834-25-000269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908834-25-000269","line_url":"/filing/0000908834-25-000269#line-1","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"Lantheus Holdings, Inc.","issuer_ticker":"LNTH","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"PATEL RAJIV A; Roberts Thomas G. Jr.; Saito Edric C.; Seybold William; Short Daniel S.; Spokes Andrew J M; WEHRLY MARK C; Warren John R.","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41000.0,"shares_display":"41,000","price_per_share":55.34,"price_display":"55.34","price_state":"stated","total_value":2268940.0,"total_display":"2,268,940.00","shares_owned_after":6842227.0,"shares_owned_after_display":"6,842,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-21","scope":"insider"},{"id":5209174,"accession":"0001209191-21-064382","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064382","line_url":"/filing/0001209191-21-064382#line-2","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Playa Hotels & Resorts N.V.","issuer_ticker":"PLYA","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Linn Michael G; PATEL RAJIV A; Dreyfuss Philip D; Kim David T; Roberts Thomas G. Jr.; Fisch Michael B.","owner_url":null,"role":"Director, Other","officer_title":null,"security_title":"Ordinary Shares, par value Euro 0.10 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7937523.0,"shares_display":"7,937,523","price_per_share":8.12,"price_display":"8.12","price_state":"stated","total_value":64452686.76,"total_display":"64,452,686.76","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-15","scope":"insider"},{"id":5209171,"accession":"0001209191-21-064382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-064382","line_url":"/filing/0001209191-21-064382#line-1","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Playa Hotels & Resorts N.V.","issuer_ticker":"PLYA","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Linn Michael G; PATEL RAJIV A; Dreyfuss Philip D; Kim David T; Roberts Thomas G. Jr.; Fisch Michael B.","owner_url":null,"role":"Director, Other","officer_title":null,"security_title":"Ordinary Shares, par value Euro 0.10 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":415030.0,"shares_display":"415,030","price_per_share":8.12,"price_display":"8.12","price_state":"stated","total_value":3370043.6,"total_display":"3,370,043.60","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-15","scope":"insider"},{"id":5333522,"accession":"0001209191-21-034820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-034820","line_url":"/filing/0001209191-21-034820#line-2","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Playa Hotels & Resorts N.V.","issuer_ticker":"PLYA","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Linn Michael G; Fisch Michael B.; Kim David T; Roberts Thomas G. Jr.; PATEL RAJIV A; Dreyfuss Philip D","owner_url":null,"role":"Director, Other","officer_title":null,"security_title":"Ordinary Shares, par value Euro 0.10 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6312264.0,"shares_display":"6,312,264","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":43428376.32,"total_display":"43,428,376.32","shares_owned_after":7937523.0,"shares_owned_after_display":"7,937,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-21","scope":"insider"},{"id":5333517,"accession":"0001209191-21-034820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034820","line_url":"/filing/0001209191-21-034820#line-1","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Playa Hotels & Resorts N.V.","issuer_ticker":"PLYA","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Linn Michael G; Fisch Michael B.; Kim David T; Roberts Thomas G. Jr.; PATEL RAJIV A; Dreyfuss Philip D","owner_url":null,"role":"Director, Other","officer_title":null,"security_title":"Ordinary Shares, par value Euro 0.10 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":330050.0,"shares_display":"330,050","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":2270744.0,"total_display":"2,270,744.00","shares_owned_after":415030.0,"shares_owned_after_display":"415,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-21","scope":"insider"},{"id":3132976,"accession":"0001214659-20-005727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-005727","line_url":"/filing/0001214659-20-005727#line-2","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Dreyfuss Philip D; FARALLON CAPITAL MANAGEMENT LLC; FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Fisch Michael B.; Kim David T; Linn Michael G; PATEL RAJIV A; Roberts Thomas G. Jr.; Zone Healthcare Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":7600000.0,"total_display":"7,600,000.00","shares_owned_after":1918819.0,"shares_owned_after_display":"1,918,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":4538143,"accession":"0001182489-17-000370","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-10","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81462.0,"shares_display":"81,462","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":293263.2,"total_display":"293,263.20","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-20","scope":"insider"},{"id":4538140,"accession":"0001182489-17-000370","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-9","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72234.0,"shares_display":"72,234","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":260042.4,"total_display":"260,042.40","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-20","scope":"insider"},{"id":4538137,"accession":"0001182489-17-000370","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-8","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52843.0,"shares_display":"52,843","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":190234.8,"total_display":"190,234.80","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-20","scope":"insider"},{"id":4538134,"accession":"0001182489-17-000370","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-7","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3414.0,"shares_display":"3,414","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":12290.4,"total_display":"12,290.40","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-20","scope":"insider"},{"id":4538132,"accession":"0001182489-17-000370","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-6","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129.0,"shares_display":"129","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":464.4,"total_display":"464.40","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-20","scope":"insider"},{"id":4538131,"accession":"0001182489-17-000370","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-5","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1492872.0,"shares_display":"1,492,872","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":5374339.2,"total_display":"5,374,339.20","shares_owned_after":81462.0,"shares_owned_after_display":"81,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-20","scope":"insider"},{"id":4538129,"accession":"0001182489-17-000370","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-4","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1323777.0,"shares_display":"1,323,777","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":4765597.2,"total_display":"4,765,597.20","shares_owned_after":72234.0,"shares_owned_after_display":"72,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-20","scope":"insider"},{"id":4538126,"accession":"0001182489-17-000370","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-3","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":968413.0,"shares_display":"968,413","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":3486286.8,"total_display":"3,486,286.80","shares_owned_after":52843.0,"shares_owned_after_display":"52,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-20","scope":"insider"},{"id":4538123,"accession":"0001182489-17-000370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-2","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62567.0,"shares_display":"62,567","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":225241.2,"total_display":"225,241.20","shares_owned_after":3414.0,"shares_owned_after_display":"3,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-20","scope":"insider"},{"id":4538120,"accession":"0001182489-17-000370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370#line-1","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2371.0,"shares_display":"2,371","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":8535.6,"total_display":"8,535.60","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-20","scope":"insider"},{"id":2727771,"accession":"0001182489-16-000974","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-24","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9554.0,"shares_display":"9,554","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":32101.44,"total_display":"32,101.44","shares_owned_after":2648696.0,"shares_owned_after_display":"2,648,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727767,"accession":"0001182489-16-000974","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-23","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7458.0,"shares_display":"7,458","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":25058.88,"total_display":"25,058.88","shares_owned_after":2067651.0,"shares_owned_after_display":"2,067,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727764,"accession":"0001182489-16-000974","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-22","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3303.0,"shares_display":"3,303","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":11098.08,"total_display":"11,098.08","shares_owned_after":915583.0,"shares_owned_after_display":"915,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727753,"accession":"0001182489-16-000974","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-21","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3007.0,"shares_display":"3,007","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":10103.52,"total_display":"10,103.52","shares_owned_after":833845.0,"shares_owned_after_display":"833,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727750,"accession":"0001182489-16-000974","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-20","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":3024.0,"total_display":"3,024.00","shares_owned_after":249462.0,"shares_owned_after_display":"249,462","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727744,"accession":"0001182489-16-000974","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-19","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":756.0,"shares_display":"756","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":2540.16,"total_display":"2,540.16","shares_owned_after":209577.0,"shares_owned_after_display":"209,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727738,"accession":"0001182489-16-000974","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-18","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":440.0,"shares_display":"440","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":1478.4,"total_display":"1,478.40","shares_owned_after":122006.0,"shares_owned_after_display":"122,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727734,"accession":"0001182489-16-000974","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-17","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3244.0,"shares_display":"3,244","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":10899.84,"total_display":"10,899.84","shares_owned_after":899268.0,"shares_owned_after_display":"899,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider"},{"id":2727729,"accession":"0001182489-16-000974","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-16","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65694.0,"shares_display":"65,694","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":208906.92,"total_display":"208,906.92","shares_owned_after":2639142.0,"shares_owned_after_display":"2,639,142","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727723,"accession":"0001182489-16-000974","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-15","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51283.0,"shares_display":"51,283","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":163079.94,"total_display":"163,079.94","shares_owned_after":2060193.0,"shares_owned_after_display":"2,060,193","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727712,"accession":"0001182489-16-000974","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-14","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22710.0,"shares_display":"22,710","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":72217.8,"total_display":"72,217.80","shares_owned_after":912280.0,"shares_owned_after_display":"912,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727694,"accession":"0001182489-16-000974","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-13","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22304.0,"shares_display":"22,304","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":70926.72,"total_display":"70,926.72","shares_owned_after":896024.0,"shares_owned_after_display":"896,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727687,"accession":"0001182489-16-000974","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-12","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20680.0,"shares_display":"20,680","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":65762.4,"total_display":"65,762.40","shares_owned_after":830838.0,"shares_owned_after_display":"830,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727682,"accession":"0001182489-16-000974","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-11","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6187.0,"shares_display":"6,187","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":19674.66,"total_display":"19,674.66","shares_owned_after":248562.0,"shares_owned_after_display":"248,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727677,"accession":"0001182489-16-000974","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-10","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5198.0,"shares_display":"5,198","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":16529.64,"total_display":"16,529.64","shares_owned_after":208821.0,"shares_owned_after_display":"208,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727672,"accession":"0001182489-16-000974","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-9","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3026.0,"shares_display":"3,026","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":9622.68,"total_display":"9,622.68","shares_owned_after":121566.0,"shares_owned_after_display":"121,566","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":2727668,"accession":"0001182489-16-000974","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-8","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69752.0,"shares_display":"69,752","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":221811.36,"total_display":"221,811.36","shares_owned_after":2573448.0,"shares_owned_after_display":"2,573,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":2727663,"accession":"0001182489-16-000974","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-7","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54451.0,"shares_display":"54,451","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":173154.18,"total_display":"173,154.18","shares_owned_after":2008910.0,"shares_owned_after_display":"2,008,910","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":2727659,"accession":"0001182489-16-000974","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-6","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24112.0,"shares_display":"24,112","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":76676.16,"total_display":"76,676.16","shares_owned_after":889570.0,"shares_owned_after_display":"889,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":2727656,"accession":"0001182489-16-000974","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-5","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23681.0,"shares_display":"23,681","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":75305.58,"total_display":"75,305.58","shares_owned_after":873720.0,"shares_owned_after_display":"873,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":2727650,"accession":"0001182489-16-000974","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-4","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21959.0,"shares_display":"21,959","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":69829.62,"total_display":"69,829.62","shares_owned_after":810158.0,"shares_owned_after_display":"810,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":2727643,"accession":"0001182489-16-000974","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-3","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6569.0,"shares_display":"6,569","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":20889.42,"total_display":"20,889.42","shares_owned_after":242375.0,"shares_owned_after_display":"242,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":2727630,"accession":"0001182489-16-000974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-2","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5519.0,"shares_display":"5,519","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":17550.42,"total_display":"17,550.42","shares_owned_after":203623.0,"shares_owned_after_display":"203,623","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":2727622,"accession":"0001182489-16-000974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974#line-1","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3213.0,"shares_display":"3,213","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":10217.34,"total_display":"10,217.34","shares_owned_after":118540.0,"shares_owned_after_display":"118,540","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":8773006,"accession":"0001182489-15-000697","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-16","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3600.0,"shares_display":"3,600","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":23328.0,"total_display":"23,328.00","shares_owned_after":2503696.0,"shares_owned_after_display":"2,503,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8773005,"accession":"0001182489-15-000697","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-15","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2810.0,"shares_display":"2,810","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":18208.8,"total_display":"18,208.80","shares_owned_after":1954459.0,"shares_owned_after_display":"1,954,459","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8773004,"accession":"0001182489-15-000697","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-14","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1245.0,"shares_display":"1,245","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":8067.6,"total_display":"8,067.60","shares_owned_after":865458.0,"shares_owned_after_display":"865,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8773003,"accession":"0001182489-15-000697","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-13","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1222.0,"shares_display":"1,222","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":7918.56,"total_display":"7,918.56","shares_owned_after":850039.0,"shares_owned_after_display":"850,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8773002,"accession":"0001182489-15-000697","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-12","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1133.0,"shares_display":"1,133","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":7341.84,"total_display":"7,341.84","shares_owned_after":788199.0,"shares_owned_after_display":"788,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8773001,"accession":"0001182489-15-000697","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-11","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":339.0,"shares_display":"339","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":2196.72,"total_display":"2,196.72","shares_owned_after":235806.0,"shares_owned_after_display":"235,806","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8773000,"accession":"0001182489-15-000697","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-10","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":285.0,"shares_display":"285","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":1846.8,"total_display":"1,846.80","shares_owned_after":198104.0,"shares_owned_after_display":"198,104","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8772999,"accession":"0001182489-15-000697","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-9","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":166.0,"shares_display":"166","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":1075.68,"total_display":"1,075.68","shares_owned_after":115327.0,"shares_owned_after_display":"115,327","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider"},{"id":8772998,"accession":"0001182489-15-000697","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-8","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":575.0,"total_display":"575.00","shares_owned_after":2500096.0,"shares_owned_after_display":"2,500,096","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-09","filed_date":"2015-09-11","scope":"insider"}],"next_cursor":"2015-09-09|8772998","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001521036","name":"Lantheus Holdings, Inc.","url":"/issuer/0001521036","role":"Other","n_filings":1,"first_seen":"2025-08-21","last_seen":"2025-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001692412","name":"Playa Hotels & Resorts N.V.","url":"/issuer/0001692412","role":"Other","n_filings":2,"first_seen":"2021-05-21","last_seen":"2021-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-06-17","last_seen":"2020-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001281774","name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","url":"/issuer/0001281774","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2017-06-20","last_seen":"2017-06-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001618561","name":"Nexvet Biopharma plc","url":"/issuer/0001618561","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2015-09-11","last_seen":"2016-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001482512","name":"Hudson Pacific Properties, Inc.","url":"/issuer/0001482512","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2010-07-01","last_seen":"2015-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000859475","name":"TRIDENT MICROSYSTEMS INC","url":"/issuer/0000859475","role":"Ten percent owner, Other","n_filings":7,"first_seen":"2012-11-28","last_seen":"2012-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001268984","name":"REDDY ICE HOLDINGS INC","url":"/issuer/0001268984","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2009-03-25","last_seen":"2009-03-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001453042","retrieved_at":"2026-08-21T13:31:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}